Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study

Background: The majority of therapies have generally targeted fasting glucose control, and current mealtime insulin therapies have longer time action profiles than that of endogenously secreted insulin. The primary purpose of this study was to assess both glucose time-in-range (TIR: 70–180 mg/dL) an...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Diabetes Technol Ther
Autori principali: Akturk, Halis Kaan, Snell-Bergeon, Janet K., Rewers, Amanda, Klaff, Leslie J., Bode, Bruce W., Peters, Anne L., Bailey, Timothy S., Garg, Satish K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Mary Ann Liebert, Inc., publishers 2018
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6161328/
https://ncbi.nlm.nih.gov/pubmed/30207748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2018.0200
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi